Patient advocacy organizations are a highly influential voice in the healthcare system, providing a critical link to real-world patient experiences. Armed with a deep understanding of what it is like to live with chronic conditions such as multiple sclerosis (MS), spinal muscular atrophy (SMA), or one of the conditions currently under research by Biogen scientists, patient advocacy organisations help us better understand unmet patient needs, shape our discovery and development programmes and enhance our treatments and patient outcomes.
For Biogen, these organisations provide a critical link to real-world patient preferences and experiences. From collecting insights to help us shape R&D; to partnering to improve disease awareness and access; developing public policy that encourages research, innovation and access; they help us understand the patient’s perspective so that we may incorporate those important insights throughout the continuum of drug development at Biogen.
Learn more about our work with patient advocacy organisations in our 2016 Corporate Citizenship Report.